Fundz

Pelthos Therapeutics

Durham, North Carolina, United States · Biotechnology, Healthcare, Health Care

Pelthos Therapeutics Inc. was formerly known as Chromocell Therapeutics Corp. Pelthos Therapeutics specializes in developing treatments for molluscum contagiosum infections. The company is known for its FDA-approved drug ZELSUVMI, which is the first prescription treatment for home use. Pelthos is committed to advancing patient care through innovative therapeutic solutions. It operates as a subsidi

Key facts

Headquarters
Durham, North Carolina, United States
Employees
83
Industries
Biotechnology, Healthcare, Health Care
Status
Public (PTHS)
Website
pelthos.com
LinkedIn
Company page

Recent activity at Pelthos Therapeutics

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Pelthos Therapeutics funding history

DateRoundAmount
Oct 2026Venture$57.5M
Nov 2025Venture$18.0M
Jul 2025Venture$50.1M
Jul 2024Venture$750K

Leadership

  • Melvin Whitehead, Senior Vice President, Operations
  • Sai Rangarao, Chief Commercial Officer (CCO)
  • John M. Gay, Chief Financial Officer
  • Richard Malamut, Director
  • Ezra Friedberg, Director
  • Todd Davis, Director
  • Eric Lang, Executive Officer
  • Francis Knuettel, Executive Officer
  • Carri Geer, Chief Technology Officer
  • Suzie Paulson, Vice President of Human Resources
  • Scott Plesha, Chief Executive Officer

Verified email and direct lines for Pelthos Therapeutics’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Companies similar to Pelthos Therapeutics

  • Biofrontera · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
  • AIM ImmunoTech · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
  • Aquestive Therapeutics, Inc. · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
  • Retension Pharmaceuticals · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
  • Os Therapies · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics

About Pelthos Therapeutics: questions and answers

What does Pelthos Therapeutics do?

Pelthos Therapeutics Inc. was formerly known as Chromocell Therapeutics Corp. Pelthos Therapeutics specializes in developing treatments for molluscum contagiosum infections. The company is known for its FDA-approved drug ZELSUVMI, which is the first prescription treatment for home use. Pelthos is committed to advancing patient care through innovative therapeutic solutions. It operates as a subsidi

Where is Pelthos Therapeutics headquartered?

Pelthos Therapeutics is headquartered in Durham, North Carolina, United States.

How many employees does Pelthos Therapeutics have?

Pelthos Therapeutics has about 83 employees.

Has Pelthos Therapeutics raised funding?

Yes. Fundz has recorded 4 funding events for Pelthos Therapeutics. The most recent, $57.5M, was in Oct 2026.

Who leads Pelthos Therapeutics?

Melvin Whitehead is a Senior Vice President, Operations at Pelthos Therapeutics.

What is the latest news on Pelthos Therapeutics?

On Oct 30, 2026, Chromocell Therapeutics

Is Pelthos Therapeutics a public company?

Yes. Pelthos Therapeutics is publicly traded under the ticker PTHS.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Pelthos Therapeutics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.